24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Ichilov Medical Center
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:24
Meta forced to unmask anonymous Facebook users in defamation lawsuit
10:00
Exit dreams and corporate reality: Untold challenges of Israeli tech acquisitions
09:54
What went wrong at AnyVision? Lessons from a $352M flameout
08:52
2025 is bringing “a search for meaning” among Israelis, inspiring entrepreneurial dreams
More stories
Buzz
Most popular
Daily
Weekly
1
Facial recognition firm Oosto, formerly AnyVision, sold for $125M after raising $352M
2
"Wiz is the world's fastest-growing cyber company and together we can build the largest security company to come out of Israel"
3
Warburg Pincus Signs Deal to Acquire Israeli Credit Card Issuer for $680 Million
4
Survey finds 50% of high-tech startups in Israel may exhaust funds in six months
5
"Everyone will be a manager" - what the world of work will look like with AI agents
More news
Ichilov Medical Center
2 stories about Ichilov Medical Center
"The genome project will change the face of medicine in Israel and save human lives"
10.11.24
|
Roni Dori
Psifas is an ambitious new genome project aiming to create a genetic database of Israel’s citizens, with a budget of NIS 250 million. The collected information already provides information that will make it possible to treat life-threatening diseases in the subjects. The hope is that after accumulating 100,000 samples, the database will help jumpstart the biotech industry. CEO Prof. Gabi Barbash: "Psifas is a great achievement and advantage for Israel, which aspires to become a global hub of biotechnological information."
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov
Please ensure Javascript is enabled for purposes of
website accessibility